Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Niacin/Laropiprant for Atherosclerosis in HIV
NCT01683656Phase 4Terminated
- Sponsor
- Alexandra Calmy
- Start
- Aug 2012
- Primary completion
- Jul 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of laropiprant + niacin in atherosclerosis, sponsored by Alexandra Calmy. Started Aug 2012; status: terminated.
02
Drugs
laropiprant + niacin
03
Conditions
atherosclerosis
Beyond the preview
Go deeper on NCT01683656.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01683656.